Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

LOC338588 Inhibitors

LOC338588 inhibitors constitute a specialized chemical class designed to selectively target and modulate the function of the non-coding RNA LOC338588. As a member of the expansive family of non-coding RNAs, LOC338588 is categorized as a long intergenic non-protein coding RNA (lincRNA). LincRNAs, despite their inability to encode proteins, play crucial roles in regulating diverse cellular processes. The inhibitors developed for LOC338588 are intricately designed to interact with the specific molecular structure of this non-coding RNA, aiming to disrupt its normal interactions within the cellular environment and potentially influence various cellular regulatory pathways.

The molecular architecture of LOC338588 inhibitors is precisely tailored to engage specific binding sites on the RNA molecule, inducing changes in its conformation and dynamics. This interaction holds the potential to impact the regulatory functions that LOC338588 may exert in cellular processes. In laboratory research, these inhibitors serve as indispensable tools, enabling scientists to probe the nuanced functions of LOC338588 in various cellular contexts. By manipulating the function of LOC338588, researchers aim to unravel the complex mechanisms of non-coding RNA-mediated regulation, contributing to a deeper understanding of the intricate network of molecular players orchestrating cellular processes and potential roles in cellular homeostasis. The study of LOC338588 inhibitors stands at the forefront of advancing our comprehension of non-coding RNA biology and the nuanced roles these molecules play in the intricate web of cellular regulatory mechanisms.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

A histone deacetylase inhibitor that can modify chromatin structure and potentially downregulate gene expression, including lncRNAs.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

A hypomethylating agent that may cause DNA demethylation, potentially affecting the transcription of genes including lncRNAs.

Rocaglamide

84573-16-0sc-203241
sc-203241A
sc-203241B
sc-203241C
sc-203241D
100 µg
1 mg
5 mg
10 mg
25 mg
$275.00
$474.00
$1639.00
$2497.00
$5344.00
4
(1)

A natural product that inhibits translation initiation and might reduce lncRNA levels post-transcriptionally.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$269.00
$1050.00
26
(2)

A potent inhibitor of RNA polymerase II, which could lead to a broad reduction in RNA transcription, including that of LINC00705.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

By binding to DNA, it inhibits RNA polymerase movement, which could decrease the transcription of LINC00705.

DRB

53-85-0sc-200581
sc-200581A
sc-200581B
sc-200581C
10 mg
50 mg
100 mg
250 mg
$43.00
$189.00
$316.00
$663.00
6
(1)

An adenosine analog that inhibits RNA synthesis by targeting RNA polymerase II, potentially reducing lncRNA levels.

Flavopiridol

146426-40-6sc-202157
sc-202157A
5 mg
25 mg
$78.00
$259.00
41
(3)

A cyclin-dependent kinase inhibitor that can block RNA polymerase II-mediated transcription elongation, impacting lncRNA expression.

(±)-JQ1

1268524-69-1sc-472932
sc-472932A
5 mg
25 mg
$231.00
$863.00
1
(0)

A BET bromodomain inhibitor that can modulate chromatin structure and gene expression, potentially reducing LINC00705 transcription.

Sinefungin

58944-73-3sc-203263
sc-203263B
sc-203263C
sc-203263A
1 mg
100 mg
1 g
10 mg
$271.00
$5202.00
$40368.00
$704.00
4
(1)

An inhibitor of S-adenosylmethionine-dependent methyltransferases that may affect RNA methylation and gene expression.

FK-866

658084-64-1sc-205325
sc-205325A
5 mg
10 mg
$143.00
$250.00
12
(1)

A histone deacetylase inhibitor that can lead to changes in chromatin structure and affect the expression of various genes.